Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Crohn's disease Stories

2014-04-16 11:40:27

A new study has shed light on the factors likely to lead to the development of a rare condition affecting the inner ear. In the most comprehensive study of Ménière's Disease to date, researchers at the University of Exeter Medical School have been able to suggest what goes wrong in the body when people develop the disease, and provide an insight into factors that lead to its development. Ménière's Disease can cause tinnitus, hearing loss, vertigo attacks and a feeling of pressure...

2014-04-12 23:00:25

Transparency Market Research Report Added "Inflammatory Bowel Disease Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its database. Browse full report: http://www.transparencymarketresearch.com/inflammatory-bowel-disease.html. Albany, New York USA (PRWEB) April 12, 2014 Inflammatory bowel disease (IBD) is an immune-mediated disease in which the body’s own immune system attacks the parts of the digestive system of the human body....

Crohn's Disease Associated With Microbiome Imbalance In The Gut
2014-03-13 05:18:52

Lee Rannals for redOrbit.com - Your Universe Online Researchers writing in the journal Cell Host & Microbe say they have found how the intestinal microbial population of newly diagnosed Crohn’s disease patients is different from other individuals. The team says that Crohn’s patients showed increased levels of harmful bacteria and reduced levels of the beneficial bacteria usually found in a healthy gastrointestinal tract. The research included data from the RISK Stratification...

2014-03-12 08:30:38

The Jeffrey Epstein VI Foundation funds groundbreaking research to prevent Crohns and Colitis Disease. NEW YORK, March 12, 2014 /PRNewswire/ -- Crohns and Colitis Disease is a chronic disease of the lower intestinal track, causing inflammation and a host of crippling symptoms from ulcers to intestinal rupture. The disease affects approximately 700,000 Americans and many more suffer from undiagnosed irritable bowel syndrome. To date, not much is known about the ultimate cause of...

2014-03-03 08:32:34

CCFA Researchers Map Out Strategies to New Drugs and Individualized Therapy for Crohn's Disease and Ulcerative Colitis NEW YORK, March 3, 2014 /PRNewswire/ -- High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and...

2014-02-20 04:20:55

-- More than 200 artists inspired by patients in more than 40 countries NORTH CHICAGO, Ill., Feb. 20, 2014 /PRNewswire/ -- AbbVie today announced the launch of 'Perspectives - Art, Inflammation and Me', an initiative designed to add a different dimension to the current understanding of immune-mediated inflammatory diseases (IMIDs) and their impact on patients and society. More than 100 unique artistic expressions from the initiative are being debuted at the 9th Congress of the...

2014-01-29 12:27:38

OKLAHOMA CITY, Jan. 29, 2014 /PRNewswire/ -- Altheus Therapeutics, Inc. announced the USPTO has allowed patent 8,629,127 B2 covering the oral pharmaceutical composition 5-ASA (5-aminosalicylic acid) and NAC (N-acetylcysteine). Combination therapy patents are uncommon and under-appreciated in the pharmaceutical industry because the Patent Office requires surprising, unexpected, or synergistic benefits from combining active ingredients into a single formulation. Altheus' success in...

2014-01-09 08:28:44

OKLAHOMA CITY, Jan. 9, 2014 /PRNewswire/ -- Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa® Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April. (Logo: http://photos.prnewswire.com/prnh/20140109/DA43446LOGO) "Positive ZA201...

2013-12-16 08:26:04

However, Novel Agents Will Face Reimbursement and Uptake Challenges if Robust Superiority over Anti-TNFs is Lacking, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 16, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, when considering the most important attributes for prescribing emerging therapies for Crohn's disease (CD) and ulcerative colitis (UC),...

2013-12-12 08:31:40

CHESTERBROOK, Pennsylvania, December 12, 2013 /PRNewswire/ -- Patients with ulcerative colitis (UC) can find information, tips and tools to help manage their disease at http://www.ShireUCentral.com Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, is pleased to announce the launch of http://www.ShireUCentral.com, an online disease information and resource center for US patients with ulcerative colitis...